INOVIO to Present at Two Key Investor Conferences in Early September…

Event summary

INOVIO will participate in the Cantor Global Healthcare Conference on September 9, 2026, with a fireside chat at 3:20 PM ET.
The company will also present at the H.C. Wainwright 28th Annual Global Investment Conference, available virtually starting September 11, 2026.
Replays of both presentations will be available for 90 days post-event.
INOVIO's management team will conduct one-on-one meetings with investors during these conferences.

The big picture

INOVIO's participation in these high-profile investor conferences comes as the biotech sector faces increasing scrutiny over the efficacy and commercial viability of novel therapeutic approaches. The company's focus on DNA medicines positions it within a niche but growing segment of the healthcare industry, where success hinges on both scientific breakthroughs and strategic investor engagement. The upcoming presentations will be critical in gauging market appetite for INOVIO's pipeline.

What we're watching

Strategic Messaging: How INOVIO positions its DNA medicine pipeline in a competitive biotech landscape.
Investor Sentiment: Whether the conferences will shift market perception of INOVIO's growth prospects.
Pipeline Updates: The pace at which INOVIO advances its HPV, cancer, and infectious disease programs.